IL17A and myeloid sarcoma: To determine the role of T helper 17 (Th17) cells in MS reactivation after natalizumab discontinuation, Haas et al. [72] analyzed Th17 cells and IL-17 levels in the peripheral blood of 57 MS patients, before, during, and after natalizumab treatment.